These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3463813)

  • 21. [Comparison of low-dose cytosine arabinoside and aclarubicin in combination with granulocyte colony-stimulating factor to intermediate-dose cytosine arabinoside and mitoxantrone with or without etoposide in the treatment of relapsed acute myeloid leukemia].
    Saito K; Furusawa S; Yamada K; Waga K; Aoyagi A; Koike T; Arimura H; Noguchi M; Yamato H; Sakuma H
    Rinsho Ketsueki; 1995 Mar; 36(3):165-74. PubMed ID: 7540220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.
    Byrd JC; Ruppert AS; Mrózek K; Carroll AJ; Edwards CG; Arthur DC; Pettenati MJ; Stamberg J; Koduru PR; Moore JO; Mayer RJ; Davey FR; Larson RA; Bloomfield CD
    J Clin Oncol; 2004 Mar; 22(6):1087-94. PubMed ID: 15020610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group.
    Wrzesień-Kuś A; Robak T; Wierzbowska A; Lech-Marańda E; Pluta A; Wawrzyniak E; Krawczyńska A; Kuliczkowski K; Mazur G; Kiebiński M; Dmoszyńska A; Wach M; Hellmann A; Baran W; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S;
    Ann Hematol; 2005 Sep; 84(9):557-64. PubMed ID: 15856358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients.
    Di Febo A; Laurenti L; Falcucci P; Tosti ME; Fianchi L; Pagano L; Leone G
    Am J Ther; 2007; 14(4):351-5. PubMed ID: 17667210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].
    Rodríguez JN; Fernández-Jurado A; Martino ML; Diéguez JC; Moreno MV; Quesada JA; Polo B; Cañavate M; Amian A; Prados D
    Sangre (Barc); 1998 Feb; 43(1):35-9. PubMed ID: 9580427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [High-dose cytosine arabinoside administration in the treatment of refractory leukemia].
    Yoshida M; Furukawa Y; Akashi M; Komatsu N; Takeda K; Muroi K; Ikeda K; Ohsaka A; Ohta M; Suda K
    Rinsho Ketsueki; 1985 Aug; 26(8):1258-64. PubMed ID: 3865002
    [No Abstract]   [Full Text] [Related]  

  • 27. Maintenance therapy in childhood acute myeloid leukemia.
    Perel Y; Auvrignon A; Leblanc T; Michel G; Vannier JP; Dalle JH; Gandemer V; Schmitt C; Mèchinaud F; Lamagnere JP; Piguet Ch; Couillaud G; Pautard B; Baruchel A; Leverger G; ;
    Ann Hematol; 2004; 83 Suppl 1():S116-9. PubMed ID: 15124700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytosine-arabinoside in the treatment of acute leukemias].
    Böhnel J; Gingold N; Hermansky F; Pawlowski M; Stacher A
    Wien Med Wochenschr; 1972 Apr; 122(15):203-7. PubMed ID: 4527321
    [No Abstract]   [Full Text] [Related]  

  • 29. [Results of induction therapy in newly diagnosed acute myeloid leukemias in study 911 at the Institute of Hematology and Blood Transfusion].
    Lemez P; Vítek A; Jelínek J; Lukásová M; Palecek A; Sajdová J; Jedlicková A; Vorlová Z
    Vnitr Lek; 1995 Jan; 41(1):34-9. PubMed ID: 7716891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Low dose cytarabine in the treatment of acute myeloid leukemia. Apropos of 41 cases].
    Frikha M; Elloumi M; Bouaziz M; Daoud J; Mseddi S; Khanfir A; Gargouri J; Souissi T
    Bull Cancer; 1996 Dec; 83(12):996-1001. PubMed ID: 9116380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy of acute myelocytic leukemia. Daunomycin contrasted with a combination of cytosine arabinoside and 6-thioguanine.
    Poth JL; Johnson PK; George RP; Schrier SL
    Calif Med; 1972 Dec; 117(6):1-11. PubMed ID: 4508367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older.
    Bashey A; Liu L; Ihasz A; Medina B; Corringham S; Keese K; Carrier E; Castro JE; Holman P; Lane TA; Hassidim K; Ball ED
    Leuk Res; 2006 Apr; 30(4):503-6. PubMed ID: 16303178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose cytosine arabinoside in the treatment of resistant acute leukemia.
    Takaku F; Urabe A; Mizoguchi H; Yamada O; Wakabayashi Y; Miura Y; Sakamoto S; Yoshida M; Miwa S; Asano S
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):144-9. PubMed ID: 3859929
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypoplastic acute myeloid leukaemia with 7 years of complete remission by low-dose cytosine arabinoside therapy alone.
    Mori H; Fuchigami K; Nagai K; Kohno T; Maeda T; Nakamura H; Kuriyama K; Izumikawa K; Tomonaga M
    Eur J Haematol; 1995 Jul; 55(1):59-60. PubMed ID: 7615052
    [No Abstract]   [Full Text] [Related]  

  • 36. [Low doses of subcutaneous cytosine arabinoside in the treatment of patients with myelodysplastic syndromes].
    Avilés A; Tripp F; Velásquez A; Rubio ME; González-Llavén J
    Rev Invest Clin; 1988; 40(1):21-4. PubMed ID: 3165541
    [No Abstract]   [Full Text] [Related]  

  • 37. Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia.
    Saito T; Asai O; Dobashi N; Yano S; Osawa H; Takei Y; Takahara S; Ogasawara Y; Yamaguchi Y; Minami J; Usui N
    J Infect Chemother; 2006 Jun; 12(3):148-51. PubMed ID: 16826348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Megakaryoblastic leukemia (acute myelofibrosis): complete remission of a case with low-dose cytosine arabinoside].
    Palomera L; García Díez I; Woessner S; Velasco F; Torres A
    Sangre (Barc); 1988 Jun; 33(3):232-7. PubMed ID: 3175820
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of the blastic crisis of chronic myelogenous leukemia with the combination of vindesine and prednisolone, and cytosine arabinoside.
    Uzuka Y; Saito Y
    Tohoku J Exp Med; 1983 Apr; 139(4):419-20. PubMed ID: 6575487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic granulocytic leukaemia in accelerated stage treated with low dose cytosine arabinoside.
    Waage A; Hammerstrøm J; Lamvik J
    Br J Haematol; 1985 Nov; 61(3):588-9. PubMed ID: 3864489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.